Eddit
Aus coViki
(Unterschied zwischen Versionen)
| (17 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
| − | + | ||
| + | |||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
| − | |||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
| + | *'''[[Clinical guidelines and advice]]''' | ||
| − | |||
| − | |||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
| + | *'''[[Diagnosis (Laboratory)]]''' | ||
| − | |||
| − | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
| + | *'''[[Diagnosis (other modalities)]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Secretion and shedding]]''' | *'''[[Secretion and shedding]]''' | ||
| Zeile 49: | Zeile 34: | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
| + | |||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Disease Models]]''' | *'''[[Disease Models]]''' | ||
| − | |||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
| − | |||
| − | |||
| Zeile 79: | Zeile 55: | ||
*'''[[Co-Infection]]''' | *'''[[Co-Infection]]''' | ||
| − | + | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
| − | + | ||
| − | + | ||
| + | |||
| + | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
| − | + | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
| − | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
| + | |||
| + | |||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
| Zeile 101: | Zeile 80: | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
| − | |||
| − | |||
*'''[[Kidney, urology]]''' | *'''[[Kidney, urology]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[The morbid survivor]]''' | *'''[[The morbid survivor]]''' | ||
| Zeile 116: | Zeile 90: | ||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
| + | |||
| + | |||
*'''[[Registries]]''' | *'''[[Registries]]''' | ||
*'''[[Trials]]''' | *'''[[Trials]]''' | ||
| − | |||
| − | |||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
| Zeile 130: | Zeile 109: | ||
*'''[[Other routes of infection]]''' | *'''[[Other routes of infection]]''' | ||
| − | |||
| − | |||
| − | |||
*'''[[Biophysics of aerosols]]''' | *'''[[Biophysics of aerosols]]''' | ||
| + | |||
| + | |||
| + | |||
*'''[[Passive protective equipment]]''' | *'''[[Passive protective equipment]]''' | ||
| + | |||
| + | |||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
| + | |||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
| − | |||
*'''[[Socio-psychiatric aspects of the status hygienicus]]''' | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | ||
| + | |||
| + | |||
*'''[[Avoiding clinical medicine in other diseases]]''' | *'''[[Avoiding clinical medicine in other diseases]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| + | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | ||
| Zeile 167: | Zeile 146: | ||
*'''[[Host, vector, one health, atmospheric aspects]]''' | *'''[[Host, vector, one health, atmospheric aspects]]''' | ||
| + | *'''[[Origin of Covid19]]''' | ||
| + | *'''[[Epidemiology]]''' | ||
| − | |||
| − | |||
| − | *'''[[ | + | *'''[[Remission, recurrence and persistence]]''' |
| − | |||
| − | |||
| − | |||
| Zeile 192: | Zeile 168: | ||
*'''[[Lost people]]''' | *'''[[Lost people]]''' | ||
| − | |||
| − | |||
*'''[[Lost civilization]]''' | *'''[[Lost civilization]]''' | ||
| Zeile 201: | Zeile 175: | ||
*'''[[History of covid19 exploration]]''' | *'''[[History of covid19 exploration]]''' | ||
| − | + | *'''[[misc.]]''' | |
| − | *'''[[ | + | *'''[[Research tools]]''' |
| − | |||
{{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} | ||
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} | ||
| + | |||
*'''[[PrePrint scene]]''' | *'''[[PrePrint scene]]''' | ||
| Zeile 216: | Zeile 191: | ||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
| − | + | ||
*'''[[Current state of coviki.org]]''' | *'''[[Current state of coviki.org]]''' | ||
*'''[[on-topic personal thoughts]]''' | *'''[[on-topic personal thoughts]]''' | ||
Aktuelle Version vom 7. Juni 2020, 22:19 Uhr
27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system
